-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Amrize, Raises Price Target to $64

Benzinga·01/15/2026 14:43:19
Listen to the news
Oppenheimer analyst Bryan Blair maintains Amrize (NYSE:AMRZ) with a Outperform and raises the price target from $62 to $64.